Credent Wealth Management Lands Two New Advisor Firms
25 avr. 2024 09h00 HE | Credent Wealth Management
Two independent RIA's join Credent Wealth Management's partnership model and capitalize on exponential growth with a seamless transition.
dres.jpg
Dresner Partners Advised Crispy Edge on Its Sale to Lulu Restaurant Group
22 avr. 2024 11h00 HE | Dresner Partners
Dresner Partners is pleased to announce that it advised Crispy Edge™, LLC on its sale to Lulu Restaurant Group, LLC.
Carmell
Carmell Announces $3.0 Million Private Placement
04 avr. 2024 08h30 HE | Carmell Corporation
PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
fininst_logo.jpg
Financial Institutions, Inc. Announces Sale of the Assets of SDN Insurance Agency to NFP
01 avr. 2024 08h55 HE | Financial Institutions, Inc.
$27.0 million all cash transaction, representing ~4.0x 2023 insurance income, supports Financial Institutions, Inc.’s earnings and capital position and allows for reinvestment to support its core...
Landing Wordmark Green_Digital (1).png
Landing Acquires Barsala to Fuel Momentum Across Multifamily Sector
28 mars 2024 09h00 HE | Landing
BIRMINGHAM, Ala., March 28, 2024 (GLOBE NEWSWIRE) -- Landing, the company behind the first membership for flexible apartment living, announced today that it has acquired Barsala, a leading...
Screen Shot 2020-12-15 at 6.21.20 PM.png
JumpCloud Acquires Resmo for Next Gen IT, SaaS, and Cloud Asset Management
19 mars 2024 08h00 HE | JumpCloud
LOUISVILLE, Colo., March 19, 2024 (GLOBE NEWSWIRE) -- JumpCloud Inc., today announced it has acquired Resmo, an asset management and SaaS security solution for modern, cloud-native IT and SecOps...
First-Wave-Logo-FINAL-RGB[1].jpg
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
14 mars 2024 06h00 HE | First Wave BioPharma, Inc.
Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease James Sapirstein, Chairman and Chief Executive Officer, to continue leading First Wave...
Vaultinum-couleur (1).png
Vaultinum to showcase Tech Due Diligence Solutions at Tech Innovation Conference in London
07 mars 2024 10h18 HE | Vaultinum
Vaultinum to showcase Tech Due Diligence Solutions at Tech Innovation Conference in London
Mio_Logo_Lrg.jpg
Miovision acquires V2X leader TTS
04 mars 2024 08h00 HE | Miovision
Miovision has made its sixth acquisition: Traffic Technology Services (TTS) – the leading provider of connected vehicle technologies.
Vencora Logo Red-Black.jpg
Vencora acquires CREALOGIX
22 févr. 2024 01h00 HE | Vencora
Vencora announces the settlement of its public tender offer for all publicly held registered shares of CREALOGIX